Tributary Capital Management LLC Sells 1,485 Shares of Addus HomeCare Co. (NASDAQ:ADUS)

Tributary Capital Management LLC trimmed its holdings in Addus HomeCare Co. (NASDAQ:ADUS) by 0.7% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 207,761 shares of the company’s stock after selling 1,485 shares during the quarter. Addus HomeCare comprises about 1.8% of Tributary Capital Management LLC’s investment portfolio, making the stock its 18th biggest holding. Tributary Capital Management LLC’s holdings in Addus HomeCare were worth $21,470,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of the business. Chatham Capital Group Inc. increased its stake in shares of Addus HomeCare by 15.1% in the 1st quarter. Chatham Capital Group Inc. now owns 21,344 shares of the company’s stock worth $2,206,000 after acquiring an additional 2,795 shares in the last quarter. Guidance Capital Inc. increased its stake in shares of Addus HomeCare by 71.6% in the 1st quarter. Guidance Capital Inc. now owns 4,783 shares of the company’s stock worth $463,000 after acquiring an additional 1,996 shares in the last quarter. Bridge City Capital LLC increased its stake in shares of Addus HomeCare by 46.4% in the 1st quarter. Bridge City Capital LLC now owns 30,999 shares of the company’s stock worth $3,203,000 after acquiring an additional 9,819 shares in the last quarter. GAMMA Investing LLC increased its stake in shares of Addus HomeCare by 40.8% in the 1st quarter. GAMMA Investing LLC now owns 556 shares of the company’s stock worth $57,000 after acquiring an additional 161 shares in the last quarter. Finally, Vanguard Group Inc. increased its stake in shares of Addus HomeCare by 3.2% in the 4th quarter. Vanguard Group Inc. now owns 1,257,440 shares of the company’s stock worth $116,753,000 after acquiring an additional 38,876 shares in the last quarter. 95.35% of the stock is currently owned by institutional investors.

Addus HomeCare Stock Performance

Shares of NASDAQ ADUS traded up $0.05 during trading on Monday, reaching $116.16. 235,659 shares of the company traded hands, compared to its average volume of 132,508. The firm has a 50 day simple moving average of $110.16 and a 200-day simple moving average of $100.11. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.14. The stock has a market capitalization of $1.90 billion, a PE ratio of 28.82, a P/E/G ratio of 1.77 and a beta of 1.01. Addus HomeCare Co. has a 52-week low of $78.35 and a 52-week high of $120.53.

Addus HomeCare (NASDAQ:ADUS) last posted its quarterly earnings data on Monday, May 6th. The company reported $1.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.97 by $0.24. The company had revenue of $280.70 million for the quarter, compared to the consensus estimate of $279.49 million. Addus HomeCare had a net margin of 6.04% and a return on equity of 10.03%. The firm’s revenue was up 11.6% compared to the same quarter last year. During the same quarter last year, the firm posted $0.84 earnings per share. Equities research analysts anticipate that Addus HomeCare Co. will post 4.36 earnings per share for the current year.

Insider Buying and Selling

In related news, EVP Roberton James Stevenson sold 217 shares of the firm’s stock in a transaction that occurred on Monday, June 17th. The shares were sold at an average price of $116.13, for a total value of $25,200.21. Following the transaction, the executive vice president now owns 10,217 shares of the company’s stock, valued at $1,186,500.21. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 4.60% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several research analysts recently issued reports on ADUS shares. Stephens increased their price target on shares of Addus HomeCare from $120.00 to $128.00 and gave the stock an “overweight” rating in a research note on Friday, May 31st. TD Cowen raised their price objective on shares of Addus HomeCare from $119.00 to $128.00 and gave the company a “buy” rating in a research note on Tuesday, June 18th. Macquarie initiated coverage on shares of Addus HomeCare in a research note on Friday. They set an “outperform” rating and a $136.00 price objective for the company. Barclays lowered shares of Addus HomeCare from an “equal weight” rating to an “underweight” rating and set a $83.00 price objective for the company. in a research note on Tuesday, April 23rd. Finally, StockNews.com upgraded shares of Addus HomeCare from a “buy” rating to a “strong-buy” rating in a research note on Saturday. One research analyst has rated the stock with a sell rating, eight have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $116.25.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.